Zac-Varghese, SagenMark, PatrickBain, SteveBanerjee, DebasishChowdhury, Tahseen ADasgupta, IndranilDe, ParijatFogarty, DamianFrankel, AndrewGoldet, GabrielleKaralliedde, JanakaMallik, RitwikaMontero, RosaSharif, AdnanWahba, MonaDhatariya, KetanMcCafferty, KieranLioudaki, EiriniWinocour, Peter2024-08-222024-08-222024-07-06Zac-Varghese S, Mark P, Bain S, Banerjee D, Chowdhury TA, Dasgupta I, De P, Fogarty D, Frankel A, Goldet G, Karalliedde J, Mallik R, Montero R, Sharif A, Wahba M, Dhatariya K, McCafferty K, Lioudaki E, Winocour P. Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024. BMC Nephrol. 2024 Jul 6;25(1):216. doi: 10.1186/s12882-024-03664-1.1471-236910.1186/s12882-024-03664-138971750http://hdl.handle.net/20.500.14200/5486The contribution of chronic kidney disease (CKD) towards the risk of developing cardiovascular disease (CVD) is magnified with co-existing type 1 or type 2 diabetes. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for people with diabetic kidney disease (DKD).The primary purpose of this guideline, written by the Association of British Clinical Diabetologists (ABCD) and UK Kidney Association (UKKA) working group, is to provide practical recommendations on lipid management for members of the multidisciplinary team involved in the care of adults with DKD.en© 2024. The Author(s).Nephrology/Renal medicineDiabetesArticle